This is a renewal of a Harvard Medical School Training Program in Molecular Hematology. The program is designed to train graduate students, physicians and other biomedical scientists for academic careers focused on the study of the blood and its disorders. For this program, 60 distinguished faculty members have come together to serve as preceptors, for the students and postdoctoral fellow trainees. The program is organized around five major disciplines relevant to the broad field of Hematology-Erythroid Biology, Hemostasis-Vascular Biology, Hematopoiesis/Hematologic Malignancy, Immunology/Inflammation, Genetics, Molecular and Cellular Biology. The program selects the most promising candidates for training from a large pool of graduate students and postdoctoral fellows training at HMS and its affiliated hospitals. After nomination by a potential preceptor or program leader, trainee qualifications and research proposals are reviewed by a Steering Committee, with final appointments made by the program Co-Directors. The major training sites are the preceptor laboratories although trainees can participate in a large range of seminars, courses, laboratory and group meetings, poster sessions and other activities within the HMS community. Frequent interactions between the program Co- Directors, preceptors and trainees closely monitor the progress of each trainee. Each trainee is formally reviewed annually and meets with the program Co-Directors. Their progress is reviewed by the Steering Committee and reappointment is competitive and contingent on satisfactory progress. During the past two granting periods, 82 percent of the program's graduates have gone on to successful academic careers. Of these, 59 percent currently have funded basic science laboratories and 41 percent have successful clinical research programs. The current trainees and the program's graduates have written a total of 258 scientific papers; many in the highest quality peer-reviewed journals. New preceptors have been added to the program to provide additional strength and to reflect new areas of scientific importance. The renewal application requests a modest increase in the number of funded positions for pre and postdoctoral trainees, as the number of qualified applicants far exceeds the available positions in the current grant.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007623-20
Application #
6888922
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F1))
Program Officer
Mondoro, Traci
Project Start
1986-07-01
Project End
2006-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
20
Fiscal Year
2005
Total Cost
$442,517
Indirect Cost
Name
Harvard University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Hideshima, Teru; Qi, Jun; Paranal, Ronald M et al. (2016) Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma. Proc Natl Acad Sci U S A 113:13162-13167
Gerlach, Carmen; Moseman, E Ashley; Loughhead, Scott M et al. (2016) The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis. Immunity 45:1270-1284
Unternaehrer, Juli J; Zhao, Rui; Kim, Kitai et al. (2014) The epithelial-mesenchymal transition factor SNAIL paradoxically enhances reprogramming. Stem Cell Reports 3:691-8
Pantazatos, Dionysios; Gessner, Christopher R; Woods Jr, Virgil L et al. (2014) Changes in the Factor VIII C2 domain upon membrane binding determined by hydrogen-deuterium exchange MS. Biochem J 461:443-51
Zhao, Rui; Deibler, Richard W; Lerou, Paul H et al. (2014) A nontranscriptional role for Oct4 in the regulation of mitotic entry. Proc Natl Acad Sci U S A 111:15768-73
Cahan, Patrick; Li, Hu; Morris, Samantha A et al. (2014) CellNet: network biology applied to stem cell engineering. Cell 158:903-915
Kumar, Roshan M; Cahan, Patrick; Shalek, Alex K et al. (2014) Deconstructing transcriptional heterogeneity in pluripotent stem cells. Nature 516:56-61
Morris, Samantha A; Cahan, Patrick; Li, Hu et al. (2014) Dissecting engineered cell types and enhancing cell fate conversion via CellNet. Cell 158:889-902
Albacker, Colleen E; Storer, Narie Y; Langdon, Erin M et al. (2013) The histone methyltransferase SUV39H1 suppresses embryonal rhabdomyosarcoma formation in zebrafish. PLoS One 8:e64969
Cooney, Jeffrey D; Hildick-Smith, Gordon J; Shafizadeh, Ebrahim et al. (2013) Teleost growth factor independence (gfi) genes differentially regulate successive waves of hematopoiesis. Dev Biol 373:431-41

Showing the most recent 10 out of 89 publications